SMITHS GROUP SERVICES CORPORATION for SMITHS GROUP SERVICES CORPORATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2017 | $560,000 | Replaced |
| 3rd Quarter - Amendment | Apr 27, 2018 | $570,000 | Yes |
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
H.R.2810/S.1519, National Defense Authorization Act for Fiscal Year 2018; Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and detection solutions for the Department of Defense.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Environment/Superfund ENV
Issues related to climate change and emissions technologies.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Aviation/Airlines/Airports AVI
H.R.2825, Department of Homeland Security Authorization Act; Aviation security solutions and detection technologies for the Transportation Security Administration (TSA).
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Homeland Security HOM
H.R.3355/Senate, Department of Homeland Security Appropriations Act, 2018. H.R.2142/S.708, INTERDICT ACT. Issues related to aviation security solutions and detection technologies for the Transportation Security Administration (TSA), Department of Homeland Security (DHS), U.S. Customs and Border Protection (CBP) and the Domestic Nuclear Detection Office (DNDO). Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Explosives) technology and other border security solutions.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Trade (domestic/foreign) TRD
Issues related to the North American Free Trade Agreement (NAFTA).
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LILIA LORREIN RAMIREZ New | — |
Energy/Nuclear ENG
Conversations around liquid pipeline safety performance and voluntary standards for mechanical seals.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Taxation/Internal Revenue Code TAX
H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the repeal of the medical device excise tax. Tax reform; international tax issues; manufacturing and taxes.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Health Issues HCR
Reimbursement and policy issues related to non-opioid acute pain management.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Medicare/Medicaid MMM
S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. Reimbursement and policy issues related to non-opioid acute pain management.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Budget/Appropriations BUD
Funding for aviation security and homeland security technologies: H.R.3355/Senate, Department of Homeland Security Appropriations Act, 2018; Transportation Security Administration (TSA) funding issues. H.R.3219/Senate, Department of Defense Appropriations Act, 2018; chemical and biological counter measures.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN SCHMIDT | — |
Medical/Disease Research/Clinical Labs MED
Implementation of 21st Century Cures Act (P.L.114-255); S.1738, Medicare Home Infusion Therapy Access Act of 2017; H.R.3178, Medicare Part B Improvement Act of 2017; issues related to patient infusion therapy. H.R.2430/S.934, FDA Reauthorization Act of 2017 (P.L.115-52); regulations related to Medical Device User Fee Amendments (MDUFA). H.R.1628, American Health Care Act of 2017/Better Care Reconciliation Act of 2017; issues related to the medical device tax. Issues related to Medicare reimbursements for tracheotomy tubes. Issues related to inspection process of medical device facilities. Medical device technology related to the opioid epidemic.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Torts TOR
H.R.906, Furthering Asbestos Claim Transparency (FACT) Act of 2017; H.R.985, Fairness in Class Action Litigation and Furthering Asbestos Claim Transparency Act of 2017; Issues related to tort reform.
Foreign entity interest: Smiths Group plc -- the parent company of the registrant has interest in all activities of the registrant
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA CEGLIA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.